GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $1.71 $3.40 Friday, 19th Apr 2024 ESPR stock ended at $1.95. This is 4.28% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 14.91% from a day low at $1.71 to a day high of $1.97.
90 days $1.71 $3.40
52 weeks $0.700 $3.40

Historical Esperion Therapeutics prices

Date Open High Low Close Volume
2024-04-19 $1.78 $1.97 $1.71 $1.95 7 335 592
2024-04-18 $1.86 $2.03 $1.81 $1.87 6 001 030
2024-04-17 $1.91 $1.96 $1.81 $1.84 3 713 674
2024-04-16 $1.91 $1.99 $1.84 $1.91 6 169 639
2024-04-15 $2.12 $2.13 $1.93 $1.94 6 803 379
2024-04-12 $2.33 $2.42 $2.04 $2.14 7 503 540
2024-04-11 $2.47 $2.54 $2.25 $2.31 8 711 554
2024-04-10 $2.72 $2.72 $2.45 $2.52 8 933 811
2024-04-09 $3.00 $3.17 $2.76 $2.79 5 545 897
2024-04-08 $3.40 $3.40 $2.90 $3.03 7 884 395
2024-04-05 $3.17 $3.40 $3.02 $3.24 10 362 115
2024-04-04 $3.29 $3.40 $3.03 $3.11 11 252 933
2024-04-03 $2.95 $3.33 $2.90 $3.12 21 127 698
2024-04-02 $2.80 $3.01 $2.69 $2.88 6 282 662
2024-04-01 $2.70 $2.88 $2.63 $2.79 6 533 957
2024-03-28 $2.63 $2.80 $2.54 $2.68 8 161 413
2024-03-27 $2.77 $2.80 $2.52 $2.62 7 090 372
2024-03-26 $2.60 $2.96 $2.56 $2.70 14 652 617
2024-03-25 $2.73 $2.76 $2.31 $2.62 27 270 460
2024-03-22 $2.11 $2.40 $2.10 $2.29 8 606 450
2024-03-21 $2.24 $2.24 $2.06 $2.11 4 153 591
2024-03-20 $2.08 $2.21 $2.02 $2.19 2 593 743
2024-03-19 $2.01 $2.21 $2.01 $2.08 3 945 546
2024-03-18 $2.13 $2.13 $2.00 $2.05 3 581 724
2024-03-15 $2.00 $2.15 $1.92 $2.07 9 538 985
Click to get the best stock tips daily for free!

About Esperion Therapeutics

Esperion Therapeutics Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration a... ESPR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT